calpain inhibitor 2 has been researched along with leptomycin b in 1 studies
| Studies (calpain inhibitor 2) | Trials (calpain inhibitor 2) | Recent Studies (post-2010) (calpain inhibitor 2) | Studies (leptomycin b) | Trials (leptomycin b) | Recent Studies (post-2010) (leptomycin b) |
|---|---|---|---|---|---|
| 68 | 0 | 13 | 570 | 1 | 130 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bohrn, E; Herceg, Z; Wang, ZQ; Wesierska-Gadek, J; Wurzer, G | 1 |
1 other study(ies) available for calpain inhibitor 2 and leptomycin b
| Article | Year |
|---|---|
Differential susceptibility of normal and PARP knock-out mouse fibroblasts to proteasome inhibitors.
Topics: Acetylcysteine; Animals; Cell Line; Cell Nucleus; Cell Survival; Cells, Cultured; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Fibroblasts; Fluorescent Dyes; Humans; Immunoblotting; Indoles; Leupeptins; Mice; Mice, Knockout; Microscopy, Fluorescence; Multienzyme Complexes; Oligopeptides; Phenotype; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Proteasome Endopeptidase Complex; Proteins; Time Factors; Tumor Suppressor Protein p53 | 2000 |